Working early on in my career at the Wilmer Eye Institute (Johns Hopkins University) with photoreceptor cells, I learned how to harvest and grow rods and cone cells to advance Dr. Adler's department research working with a team of MD / Phd students.  This appreciation for understanding how to grow cells outside the body lead me into upstream processing equipment and stirred cell reactor designs to support several teams of researchers at NIH, FDA as well as USAMRID.  Developing solutions to their process with upstream technology was the beginning of my desire to generate a deeper understanding of their unit operations.  Given this thirst for knowledge I was fortunate enough to meet a pioneer in membrane technology during these technical calls, Alan S. Michaels (MIT / Founder of Amicon).  Inspired by our discussions lead me deeper down this "rabbit-hole" or some may say "black-hole" to where I supported both membrane solutions for both upstream and downstream processing.  I was truely blessed having years of training from John Rozembersky with hands on approaching for TFF process optimization as well as hosting equipment set up and training done collectively over the years.  Having a supportive management team early on in my career at Filtron Technologies, Inc by Tony MacDonald provided me the ability to constantly think, solve by design, develop and grow at a rate that has now generated solutions to clients globally.  Solving critical challenges using experiences and process solutions help meet the need for solving mRNA processing needs brought upon us in 2020 (COVID) using the Spectrum Hollow Fibers and supporting single-use flow paths with the KTF systems, now owned by Repligen. I have countless process solutions and system designs that have been formulated to provide the necessary scale-up needs within the biopharm industry.